Trial Profile
Effects of LY 2409021 on recovery from insulin-induced hypoglycaemic in Asian patients with type 2 diabetes mellitus.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Nov 2012
Price :
$35
*
At a glance
- Drugs Adomeglivant (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
- 08 Jul 2012 New trial record
- 12 Jun 2012 Results presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.